Free Trial
ETR:RHM

Rheinmetall (RHM) Stock Price, News & Analysis

Rheinmetall logo
€1,745.00 -93.50 (-5.09%)
As of 10/15/2025

About Rheinmetall Stock (ETR:RHM)

Advanced

Key Stats

Today's Range
€1,732.50
€1,832.00
50-Day Range
€1,545.50
€1,988.50
52-Week Range
€253.30
€571.80
Volume
264,985 shs
Average Volume
160,244 shs
Market Capitalization
€78.37 billion
P/E Ratio
137.94
Dividend Yield
0.33%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive RHM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Rheinmetall and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

RHM Stock News Headlines

Is *BSEM* Oversold??
BioStem Technologies Inc. (OTC: BSEM) is emerging as one of the most exciting MedTech stories of 2025. The company delivered record-breaking revenues in 2024 and Q1 2025, including $72.5 million in net revenue for Q1 — a 73% increase over the prior year — and six consecutive quarters of positive adjusted EBITDA. With cash reserves rising to $30.8 million and a growing patent portfolio of 58 issued and 68 pending patents, BSEM is scaling profitably while advancing its proprietary BioREtain® technology, which has shown clinically superior results for chronic, non-healing wounds. National recognition is adding to the momentum, with CEO Jason Matuszewski named EY Entrepreneur of the Year 2025 Florida Award winner, validating the leadership driving this high-growth MedTech powerhouse.tc pixel
See More Headlines

RHM Stock Analysis - Frequently Asked Questions

Rheinmetall's stock was trading at €614.60 at the start of the year. Since then, RHM shares have increased by 183.9% and is now trading at €1,745.00.

Based on aggregate information from My MarketBeat watchlists, some other companies that Rheinmetall investors own include NVIDIA (NVDA), Volkswagen (VOW3), Bayer Aktiengesellschaft (BAYN), Alibaba Group (BABA), Meta Platforms (META), Broadcom (AVGO) and McDonald's (MCD).

Industry, Sector and Symbol

Stock Exchange
ETR
Industry
Aerospace & Defense
Sub-Industry
N/A
Current Symbol
ETR:RHM
CIK
N/A
Fax
N/A
Employees
25,344
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
€12.65
Trailing P/E Ratio
137.94
Forward P/E Ratio
55.83
P/E Growth
0.39
Net Income
€587.64 million
Net Margins
6.44%
Pretax Margin
N/A
Return on Equity
17.11%
Return on Assets
5.62%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.25
Quick Ratio
0.57

Sales & Book Value

Annual Sales
€9.13 billion
Price / Sales
8.58
Cash Flow
€66.47 per share
Price / Cash Flow
26.25
Book Value
€85.81 per share
Price / Book
20.33

Miscellaneous

Outstanding Shares
44,909,152
Free Float
N/A
Market Cap
€78.37 billion
Optionable
Not Optionable
Beta
0.70
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

This page (ETR:RHM) was last updated on 10/16/2025 by MarketBeat.com Staff
From Our Partners